Signal transducer and activator of transcription 3-A key molecular switch for human mesenchymal stem cell proliferation

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 11, 2008, Pages 2606-2618

  Levy, Oren ^a   Dvir, Tal ^a   Tsur Gang, Orna ^a   Granot, Yosef ^a   Cohen, Smadar ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Basic fibroblast growth factor; Extracellular signal regulated kinase 1 2; Human bone marrow mesenchymal stem cells; Janus activated kinase signal transducers and activators of transcription; Platelet derived growth factor BB

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLATELET DERIVED GROWTH FACTOR BB; SERINE; STAT3 PROTEIN; TYROSINE;

ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NORMAL HUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; STEM CELL EXPANSION;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HUMANS; JANUS KINASE 2; MESENCHYMAL STEM CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 48349123212     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.05.010     Document Type: Article

References (61)

1. Aaronson D.S., and Horvath C.M. A road map for those who don't know JAK-STAT. Science 296 (2002) 1653-1655
2. Aharonovitz O., and Granot Y. Stimulation of mitogen-activated protein kinase and Na+/H+ exchanger in human platelets. Differential effect of phorbol ester and vasopressin. J Biol Chem 271 (1996) 16494-16499
3. Bianchi G., Banfi A., Mastrogiacomo M., Notaro R., Luzzatto L., Cancedda R., et al. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 287 (2003) 98-105
4. Bills C.E., Eisenberg H., and Pallante S.L. Complexes of organic acids with calcium phosphate: the von Kossa stain as a clue to the composition of bone mineral. Johns Hopkins Med J 128 (1971) 194-207
5. Boilly B., Vercoutter-Edouart A.S., Hondermarck H., Nurcombe V., and Le Bourhis X. FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev 11 (2000) 295-302
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
7. Cano E., and Mahadevan L.C. Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20 (1995) 117-122
8. Celil A.B., Hollinger J.O., and Campbell P.G. Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J Cell Biochem 95 (2005) 518-528
9. Chen S., Liu Z., Tian N., Zhang J., Yei F., Duan B., et al. Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. J Invasive Cardiol 18 (2006) 552-556
10. Chen S.L., Fang W.W., Qian J., Ye F., Liu Y.H., Shan S.J., et al. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Chin Med J (Engl) 117 (2004) 1443-1448
11. Chen X.D., Dusevich V., Feng J.Q., Manolagas S.C., Jilka R.L., Tezuka K., et al. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Miner Res 22 (2007) 1943-1956
12. Decker T., and Kovarik P. Serine phosphorylation of STATs. Oncogene 19 (2000) 2628-2637
13. Deo D.D., Axelrad T.W., Robert E.G., Marcheselli V., Bazan N.G., and Hunt J.D. Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. J Biol Chem 277 (2002) 21237-21245
14. Dudley D.T., Pang L., Decker S.J., Bridges A.J., and Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 92 (1995) 7686-7689
15. Erices A., Conget P., Rojas C., and Minguell J.J. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. Exp Cell Res 280 (2002) 24-32
16. Gruber R., Karreth F., Kandler B., Fuerst G., Rot A., Fischer M.B., et al. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets 15 (2004) 29-35
17. Heldin C.H., and Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79 (1999) 1283-1316
18. Heo J.S., Lee Y.J., and Han H.J. EGF stimulates proliferation of mouse embryonic stem cells: involvement of Ca2+ influx and p44/42 MAPKs. Am J Physiol Cell Physiol 290 (2006) C123-133
19. Honczarenko M., Le Y., Swierkowski M., Ghiran I., Glodek A.M., and Silberstein L.E. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24 (2006) 1030-1041
20. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y., et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 99 (2002) 8932-8937
21. Huckle W.R., and Earp H.S. Regulation of cell proliferation and growth by angiotensin II. Prog Growth Factor Res 5 (1994) 177-194
22. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
23. Kang Y.J., Jeon E.S., Song H.Y., Woo J.S., Jung J.S., Kim Y.K., et al. Role of c-Jun N-terminal kinase in the PDGF-induced proliferation and migration of human adipose tissue-derived mesenchymal stem cells. J Cell Biochem 95 (2005) 1135-1145
24. Katsanakis K.D., Owen C., and Zoumpourlis V. JNK and ERK signaling pathways in multistage mouse carcinogenesis: studies in the inhibition of signaling cascades as a means to understand their in vivo biological role. Anticancer Res 22 (2002) 755-759
25. Kim Y.J., Sah R.L., Doong J.Y., and Grodzinsky A.J. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 174 (1988) 168-176
26. Kingsley K., Huff J.L., Rust W.L., Carroll K., Martinez A.M., Fitchmun M., et al. ERK1/2 mediates PDGF-BB stimulated vascular smooth muscle cell proliferation and migration on laminin-5. Biochem Biophys Res Commun 293 (2002) 1000-1006
27. Kisseleva T., Bhattacharya S., Braunstein J., and Schindler C.W. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285 (2002) 1-24
28. Krampera M., Pasini A., Rigo A., Scupoli M.T., Tecchio C., Malpeli G., et al. HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood 106 (2005) 59-66
29. Kratchmarova I., Blagoev B., Haack-Sorensen M., Kassem M., and Mann M. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308 (2005) 1472-1477
30. Kyriakis J.M., App H., Zhang X.F., Banerjee P., Brautigan D.L., Rapp U.R., et al. Raf-1 activates MAP kinase-kinase. Nature 358 (1992) 417-421
31. Levy O., and Granot Y. Arginine-vasopressin activates the JAK-STAT pathway in vascular smooth muscle cells. J Biol Chem 281 (2006) 15597-15604
32. Liang H., Venema V.J., Wang X., Ju H., Venema R.C., and Marrero M.B. Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells. J Biol Chem 274 (1999) 19846-19851
33. Liechty K.W., MacKenzie T.C., Shaaban A.F., Radu A., Moseley A.M., Deans R., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6 (2000) 1282-1286
34. Liu L., Sun Z., Chen B., Han Q., Liao L., Jia M., et al. Ex vivo expansion and in vivo infusion of bone marrow-derived Flk-1+CD31-CD34- mesenchymal stem cells: feasibility and safety from monkey to human. Stem Cells Dev 15 (2006) 349-357
35. Longobardi L., O'Rear L., Aakula S., Johnstone B., Shimer K., Chytil A., et al. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res 21 (2006) 626-636
36. Mazzini L., Mareschi K., Ferrero I., Vassallo E., Oliveri G., Boccaletti R., et al. Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. Neurol Res 28 (2006) 523-526
37. McVean D.E., Patrick R.L., and Witchett C.E. An aqueous oil red O fixative stain for histological preparations. Tech Bull Regist Med Technol 35 (1965) 33-35
38. Meydan N., Grunberger T., Dadi H., Shahar M., Arpaia E., Lapidot Z., et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379 (1996) 645-648
39. Miyachi K., Fritzler M.J., and Tan E.M. Autoantibody to a nuclear antigen in proliferating cells. J Immunol 121 (1978) 2228-2234
40. Moviglia G.A., Fernandez Vina R., Brizuela J.A., Saslavsky J., Vrsalovic F., Varela G., et al. Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients. Cytotherapy 8 (2006) 202-209
41. Neubauer M., Fischbach C., Bauer-Kreisel P., Lieb E., Hacker M., Tessmar J., et al. Basic fibroblast growth factor enhances PPARgamma ligand-induced adipogenesis of mesenchymal stem cells. FEBS Lett 577 (2004) 277-283
42. Pereira R.F., Halford K.W., O'Hara M.D., Leeper D.B., Sokolov B.P., Pollard M.D., et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A 92 (1995) 4857-4861
43. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
44. Qi H., Aguiar D.J., Williams S.M., La Pean A., Pan W., and Verfaillie C.M. Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells. Proc Natl Acad Sci U S A 100 (2003) 3305-3310
45. Quarto N., and Longaker M.T. FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng 12 (2006) 1405-1418
46. Roehm N.W., Rodgers G.H., Hatfield S.M., and Glasebrook A.L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 142 (1991) 257-265
47. Rosenberg L. Chemical basis for the histological use of safranin O in the study of articular cartilage. J Bone Joint Surg Am 53 (1971) 69-82
48. Schindler C.W. Series introduction. JAK-STAT signaling in human disease. J Clin Invest 109 (2002) 1133-1137
49. Schlessinger J. How receptor tyrosine kinases activate Ras. Trends Biochem Sci 18 (1993) 273-275
50. Solchaga L.A., Penick K., Porter J.D., Goldberg V.M., Caplan A.I., and Welter J.F. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 203 (2005) 398-409
51. Tamama K., Fan V.H., Griffith L.G., Blair H.C., and Wells A. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 24 (2006) 686-695
52. Tezuka K., Yasuda M., Watanabe N., Morimura N., Kuroda K., Miyatani S., et al. Stimulation of osteoblastic cell differentiation by Notch. J Bone Miner Res 17 (2002) 231-239
53. Tibbles H.E., Vassilev A., Wendorf H., Schonhoff D., Zhu D., Lorenz D., et al. Role of a JAK3-dependent biochemical signaling pathway in platelet activation and aggregation. J Biol Chem 276 (2001) 17815-17822
54. Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 8 (1996) 205-215
55. Tsang M., and Dawid I.B. Promotion and attenuation of FGF signaling through the Ras-MAPK pathway. Sci STKE 2004 (2004) pe17
56. Tsutsumi S., Shimazu A., Miyazaki K., Pan H., Koike C., Yoshida E., et al. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288 (2001) 413-419
57. Wells A. EGF receptor. Int J Biochem Cell Biol 31 (1999) 637-643
58. Yamamoto H., Crow M., Cheng L., Lakatta E., and Kinsella J. PDGF receptor-to-nucleus signaling of p91 (STAT1 alpha) transcription factor in rat smooth muscle cells. Exp Cell Res 222 (1996) 125-130
59. Yang C.H., Murti A., Valentine W.J., Du Z., and Pfeffer L.M. Interferon alpha activates NF-kappaB in JAK1-deficient cells through a TYK2-dependent pathway. J Biol Chem 280 (2005) 25849-25853
60. Zaragosi L.E., Ailhaud G., and Dani C. Autocrine FGF2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells (2006)
61. Zhang T., Kee W.H., Seow K.T., Fung W., and Cao X. The coiled-coil domain of Stat3 is essential for its SH2 domain-mediated receptor binding and subsequent activation induced by epidermal growth factor and interleukin-6. Mol Cell Biol 20 (2000) 7132-7139